...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Results Projected to be Available on or about September 30, 2019 for Phase 3 BETonMACE Trial

Message: AD/PD Posters

AD/PD in Lisbon is going on. Dr. Jan Johansson just presented "The Epigenetic Inhibitor Apabetalone Downregulates Brain Endothelial and Microglial Cell Activation that Contributes To Neurodegenerative Disease." Poster here.


New Message
Please login to post a reply